Mergers: Pharma Must Consider Many Factors in Buy
Earlier this month, an executive from New Jersey-based Celgene blamed Receptos, a San Diego firm that it bought, for a major regulatory setback.
BIOTECH: It’s Still Low For Medtech Peers; Co. Inks International Deals
This comeback story appears to have legs.
William Welch has resigned as CEO and director of San Diego biotech Trovagene, citing personal reasons. The resignation is effective immediately.
Tandem Diabetes Care won U.S. Food and Drug Administration approval for an automated insulin technology designed to reduce the frequency and duration of low blood sugar events.
La Jolla Institute for Allergy and Immunology has elected three new board members:
A Heron Therapeutics postoperative pain anesthetic hit clinical trial targets in two additional areas, sending the company’s stock soaring.
San Diego-based Crinetics Pharmaceuticals, focused on endocrine-related cancers and endocrine disorders, appointed Alan Krasner as chief medical officer.
Sharp Mary Birch Hospital for Women & Newborns was awarded a $2.9 million grant to lead a multi-hospital, international study on a technique to increase the flow of blood from the umbilical cord into the infant’s circulatory system.
Boston-based Vertex Pharmaceuticals has opened a 170,000-square-foot research facility in San Diego, more than doubling the company’s footprint locally.
MEDICINE: High Volume a Must; Adoption Becoming Norm
In San Diego hospitals, robots are on the rise, judging by splashy marketing and an increase in robotic surgery cases, per data obtained by the San Diego Business Journal.
Damien McDevitt has joined Carlsbad’s Ionis Pharmaceuticals as chief business officer.
What does SleepScore Labs have in common with Portugal and Real Madrid? They all have Cristiano Ronaldo working for them.
A new UC San Diego center is targeting an unmet need: parasitic infections hurting poor and underserved communities.
A shareholder of San Diego-based biotech Senomyx is pushing for the company’s chairman to resign, an immediate company sale and a new board seat.